CH Biotech R&D Co (TPE:6534) Common Stock: NT$1,028 Mil (As of Dec. 2025)


TPE:6534 CH Biotech R&D Co Ltd TPE:6534
84 GF Score
Price NT$93.00
GF Value NT$100.68
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is CH Biotech R&D Co Common Stock?

CH Biotech R&D Co TPE:6534 84 Common Stock is NT$1,028 Mil as of Dec. 2025. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.68 (Fairly Valued). The stock has 1 warning sign investors should review.

CH Biotech R&D Co's quarterly common stock stayed the same from Jun. 2025 (NT$1,028 Mil) to Sep. 2025 (NT$1,028 Mil) and stayed the same from Sep. 2025 (NT$1,028 Mil) to Dec. 2025 (NT$1,028 Mil).

CH Biotech R&D Co's annual common stock stayed the same from Dec. 2023 (NT$1,028 Mil) to Dec. 2024 (NT$1,028 Mil) and stayed the same from Dec. 2024 (NT$1,028 Mil) to Dec. 2025 (NT$1,028 Mil).

CH Biotech R&D Co Common Stock Historical Data

* Premium members only.

The historical data trend for CH Biotech R&D Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CH Biotech R&D Co Common Stock Chart

CH Biotech R&D Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 844.20 970.83 1,028.00 1,028.00 1,028.00

CH Biotech R&D Co Quarterly Data
Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,028.00 1,028.00 1,028.00 1,028.00 1,028.00
TPE:6534
84GF Score
CH Biotech R&D Co Ltd TPE:6534
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CH Biotech R&D Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$1,028 Mil mean?
CH Biotech R&D Co (TPE:6534) has a Common Stock of NT$1,028 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CH Biotech R&D Co and its competitors.
Is CH Biotech R&D Co's Common Stock too high?
CH Biotech R&D Co's current Common Stock is NT$1,028 Mil. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's Common Stock compare to CTVA and CF?
CH Biotech R&D Co's Common Stock of NT$1,028 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Agriculture company?
A good Common Stock depends on the Agriculture industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CH Biotech R&D Co and its competitors. CH Biotech R&D Co's current Common Stock is NT$1,028 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Fairly Valued. The stock's GF Value™ is NT$100.68, compared to a current price of NT$93.00 — trading 7.6% below its estimated fair value. The current Common Stock is NT$1,028 Mil. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current Common Stock is NT$1,028 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?

Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued. The current stock price of NT$93.00 is trading 7.6% below its estimated GF Value™ of NT$100.68. GuruFocus considers CH Biotech R&D Co to be Fairly Valued.

Key valuation signals for TPE:6534:

  • Common Stock: NT$1,028 Mil
  • GF Value™: NT$100.68 vs. price of NT$93.00 (7.6% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CH Biotech R&D Co Business Description

Address No. 89, Wenxian Road, Nantou County, Nantou City, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score

Get the complete analysis for TPE:6534

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$93.00
Price
NT$100.68
GF Value